Crossref
Telaprevir: An Emerging Protease Inhibitor for the Treatment of Hepatitis C
Clinical Medicine Reviews in Therapeutics · 2010
DOI: 10.4137/cmrt.s1575 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Therapeutics, 2010. Verfasst von Rudolf E. Stauber.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Stauber, R. E. (2010). Telaprevir: An Emerging Protease Inhibitor for the Treatment of Hepatitis C. Clinical Medicine Reviews in Therapeutics. https://doi.org/10.4137/cmrt.s1575
Vancouver
Stauber RE. Telaprevir: An Emerging Protease Inhibitor for the Treatment of Hepatitis C. Clinical Medicine Reviews in Therapeutics. 2010. doi:10.4137/cmrt.s1575
BibTeX
@article{Stauber2010,
author = {Stauber, Rudolf E.},
title = {Telaprevir: An Emerging Protease Inhibitor for the Treatment of Hepatitis C},
journal = {Clinical Medicine Reviews in Therapeutics},
year = {2010},
doi = {10.4137/cmrt.s1575}
}
EUVIMED